ANDA approvals in 2019: Trends for the generics industry
Meenu Grover Sharma, Scholar Delhi Pharmaceutical Sciences & Research University, Principal Consultant, BusinessAssociar…
Sign in / Join
Sign in
Recover your password.
A password will be e-mailed to you.
Home » US FDA
Browsing Tag
US FDA
US FDA completes inspection of Alembic’s JV firm Aleor Derma’s Karakhadi unit
The inspection at the formulation site was conducted from January 6 to 8, 2020
Alembic Pharmaceuticals said its joint venture…
Glenmark receives ANDA approval for Deferasirox Tablets
Deferasirox Tablets for Oral Suspension, 125 mg, 250 mg and 500 mg is the the generic version of Exjade 1 Tablets for Oral…
US FDA red flags GPT Pharmaceuticals for significant violations at Hyderabad unit
Significant violations of current good manufacturing practice (CGMP) regulations for finished pharmaceuticals were observed during…
Indoco receives approval for Febuxostat Tablets from US FDA
The market size of Febuxostat Tablets in USA is over USD 500 million
Granules India gets US FDA nod for Loratadine tabs
The product will be commercialised shortly
Granules India said the US health regulator has given its approval to the…
Glenmark Pharmaceutical recalls ranitidine tablets in US
The tablets are being recalled because of the presence or potential presence of N-nitrosodimethylamine (NDMA) levels above the…
LifeSan Clinical Research undergoes unannounced successful inspection from US FDA
There were no 483 observations
LifeSan Clinical Research, a division of Centaur Pharmaceuticals recently underwent an…
Lupin launches generic Doxercalciferol injection in US
The injection is used for treatment of hyperparathyroidism
Lupin has launched its generic Doxercalciferol injection used for…
FDA gives green light to Tandem Diabetes Care Control-IQ Technology
Tandem Diabetes Care Control-IQ Technology is the first interoperable, automated insulin dosing controller designed to allow more…